The word from the manager: AM Values

'Lvmh is a way to seize any rebound in the luxury sector'

'In healthcare interesting Pfizer, Zimmer Biomet, Becton Dickinson'

Frederic Moeremans d’Emaus, Senior Equity Portfolio Manager di Valori Asset Management

3' min read

3' min read

Frederic Moeremans d'Emaus, senior equity portfolio manager at Valori Am, explains what the markets might look like in the coming months, emphasising both the importance of global growth and the sectoral valuation, which sees the US technology segment in particular with somewhat stretched valuations.

Has the pricing scenario changed for the coming months? If so, in what way? What will be the main drivers?

The stock market scenario has undergone a significant change in the last period: what is striking is the increasingly pervasive interference of the US government in the economic and monetary sphere. Examples of this are the Intel affair, Powell's change of course and the pressure exerted on the various Fed members to condition their decisions. Added to this is an environment in which the markets discount a rather optimistic scenario, while the main drivers will remain global growth trends, monetary policy decisions and geopolitical developments.

Loading...

I COMPARABLES

Loading...

Do you think the current stock market valuation is correct or do you see overvalued prices?

Valuations must always be read in relation to expectations of future growth and their actual credibility or realisability. It is undeniable that, both on a historical basis and on forward estimates, we are in the upper part of the trading range. Analysing a wide range of parameters, several signals emerge that call for caution: the market is now discounting an overly rosy scenario, even leaving aside geopolitical factors or the potential impact of new tariffs.

How will geopolitics affect the markets?

The recent meetings between the US, Russia, Europe and Ukraine have brought geopolitics back to the centre of the debate. Investors cannot overlook the risk that possible tensions will lead to new waves of volatility, directly affecting both comenergy and overall market sentiment. It also remains to be seen to what extent a positive resolution of the conflict in Ukraine could translate into strong spending commitments for EU countries.

IL TITOLO IN BORSA

Loading...

What are the unknowns you fear most?

.

The first quarter has already shown less vigorous global growth. Should the second half of the year fail to reverse this trend, the recessionary spectre could reappear and lead to a significant correction in stock markets. This represents the main risk to be taken seriously. Another source of uncertainty will be the impact of US tariff policy on the inflation rate.

The most promising sectors for the coming months? And those, instead, in possible bubble?

In recent years the indices have benefited from a strong sectoral concentration - especially Tech in the US and Financials in Europe - which has been extremely favourable. Today, I see opportunities mainly in sectors that are less represented in the indices and partly neglected by the markets: Energy and Healthcare fall into this category, with attractive valuations and solid medium-term prospects. I would also add luxury, which trades at a discount to its historical average: despite a phase of weakness in the very short term, it could benefit from a recovery in consumption in China. Conversely, I remain more cautious on Tech segments, which are already showing very stretched valuations and where the risk of excess is more evident.

IL CONFRONTO

Loading...

In terms of geographical areas, what are your preferences?

I would give more importance to sectoral exposure than to geographical exposure, also in view of the high incidence of US mega cap tech in the indices. I would therefore be more in favour of considering a rotation away from tech towards other, more defensive sectors, in the various geographical areas

What do the price lists of Europe and the US have in common and what differentiates them?

In both Europe and the US, the stock markets benefited from the strong concentration on a few leading sectors, which drove the overall performance. The main difference, however, lies in the sectoral composition: the US remains driven by the technology sector, which has a very significant weight in the indices (33.5% in the S&P500), while Europe has a more cyclical structure, with greater exposure to sectors such as financials and industry.

Interesting companies?

Several names in the healthcare sector, Pfizer continuing to give good quarterlies, raise earnings estimates, with strong cost discipline and an excellent pipeline with some potential blockbuster drugs, a 6.6% dividend and extremely compressed multiples. Zimmer Biomet, a global leader in prosthetics, recently acquired two companies in orthopaedic robotics (Paragon 28 and Monogram) and has with the ageing population and the desire to preserve an active lifestyle, a significant headwind. It trades at eleven times earnings with a super strong balance sheet. Becton Dickinson in medical devices. In the Energy sector, TotalEnergies remains well positioned thanks to a balanced mix of fossil fuels and renewables. In luxury, a sector whose difficulties are well known to all, Lvmh, whose latest quarterly report gave encouraging signs of domestic demand in China and stabilisation in the EU and the US, is certainly an interesting name, a prudent way for the sector to rebound. A riskier alternative, due to its strong dependence on a single brand (Gucci) could be Kering.

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti